198 related articles for article (PubMed ID: 22967071)
1. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
Roukos DH
Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071
[No Abstract] [Full Text] [Related]
2. The era of cancer discovery.
Cantley LC; Baselga J
Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
[No Abstract] [Full Text] [Related]
3. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
4. Key drivers of biomedical innovation in cancer drug discovery.
Huber MA; Kraut N
EMBO Mol Med; 2015 Jan; 7(1):12-6. PubMed ID: 25422355
[TBL] [Abstract][Full Text] [Related]
5. Somatic alterations as the basis for resistance to targeted therapies.
Blair BG; Bardelli A; Park BH
J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
[TBL] [Abstract][Full Text] [Related]
6. Tumor heterogeneity and personalized cancer medicine: are we being outnumbered?
Cirkel GA; Gadellaa-van Hooijdonk CG; Koudijs MJ; Willems SM; Voest EE
Future Oncol; 2014 Feb; 10(3):417-28. PubMed ID: 24559448
[TBL] [Abstract][Full Text] [Related]
7. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
8. Combining targeted drugs to stop resistant tumors.
Kaiser J
Science; 2011 Mar; 331(6024):1542-5. PubMed ID: 21436437
[No Abstract] [Full Text] [Related]
9. Integrative oncoproteomics strategies for anticancer drug discovery.
Liu R; Wang K; Yuan K; Wei Y; Huang C
Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311
[TBL] [Abstract][Full Text] [Related]
10. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
11. Targeted agents: the rules of combination.
Kwak EL; Clark JW; Chabner B
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749
[TBL] [Abstract][Full Text] [Related]
12. Promising strategy developed to target drug-resistant cancer cells.
Thorne J
Future Med Chem; 2014 Apr; 6(6):603. PubMed ID: 25028759
[No Abstract] [Full Text] [Related]
13. Epistatic interactions and drug response.
Weigelt B; Reis-Filho JS
J Pathol; 2014 Jan; 232(2):255-63. PubMed ID: 24105606
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026
[TBL] [Abstract][Full Text] [Related]
15. Calculated resistance in cancer.
Sawyers CL
Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
[No Abstract] [Full Text] [Related]
16. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
17. Targeting survivin in cancer: the cell-signalling perspective.
Kanwar JR; Kamalapuram SK; Kanwar RK
Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
[TBL] [Abstract][Full Text] [Related]
18. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
Lee AJ; Swanton C
Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
[TBL] [Abstract][Full Text] [Related]
19. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
20. Functional drug-gene interactions in lung cancer.
Smida M; Nijman SM
Expert Rev Mol Diagn; 2012 Apr; 12(3):291-302. PubMed ID: 22468819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
